81927-375-01 : NDC 2026 Code

81927-375-01 : Nelarabine ( Nelarabine )

Additionally :

You can get information about “81927-375-01” NDC code in 81927-375-01 in HTML format

HTML | 81927-375-01 in TXT (Plain Text) format

TXT | 81927-375-01 in PDF (Portable Document Format)

PDF | 81927-375-01 in XML format

XML formats.

NDC Code : 81927-375-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "81927-375-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (81927-375-01)  / 75 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "81927-0375-01",
    "ProductNDC": "81927-375",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Nelarabine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Nelarabine",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20250831",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA214809",
    "LabelerName": "Shorla Oncology Inc.",
    "SubstanceName": "NELARABINE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-09-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250831",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}